Alembic Pharma gets USFDA nod for Desonide Ointment

Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31Itd6g
via IFTTT

0 comments:

Post a Comment